Pediatrics

1092 questions

Question 321Question →

A 12-month-old boy is brought to the office for a routine well-child visit. Three months ago, he was hospitalized for a 5-day history of high fever, polymorphic rash, bilateral conjunctival injection, and cervical lymphadenopathy. He was diagnosed with Kawasaki disease and treated successfully with high-dose intravenous immunoglobulin (IVIG) and aspirin. He is currently taking no medications. The mother expresses concern that her son is not yet walking independently and only says "mama" and "dada" specifically. He pulls to stand, cruises along furniture, uses a neat pincer grasp, and points to objects. His length, weight, and head circumference are at the 50th percentile. Physical examination is normal. His immunization record shows he received all recommended vaccines at ages 2, 4, and 6 months. Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; defer MMR and varicella vaccines; reassure the mother

Answer

Administer inactivated vaccines (Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A), defer live vaccines (MMR and varicella), and reassure the mother regarding his normal development.
The correct approach involves administering age-appropriate inactivated vaccines (Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A), deferring live-attenuated vaccines (measles, mumps, and rubella [MMR] and varicella), and providing reassurance regarding the patient's normal development. High-dose intravenous immunoglobulin (IVIG), which this patient received for Kawasaki disease at age 9 months, contains pooled IgG antibodies. These antibodies can neutralize live-attenuated viruses, leading to a diminished immune response. Therefore, live vaccines must be deferred for up to 11 months after high-dose IVIG administration. However, IVIG does not interfere with the immune response to inactivated vaccines or toxoids, which should be administered on their regular schedule. Additionally, this patient's milestones (cruising, pincer grasp, specific 'mama'/'dada', and pointing) are entirely normal for a 12-month-old. Independent walking is generally achieved by 12 to 15 months, so the mother should be reassured without further developmental referral.

Step-by-Step Solution

1
Assess the patient's developmental milestones.
Cruising, pincer grasp, saying 'mama' and 'dada', and pointing are normal milestones for a 12-month-old.
To address the mother's concern and determine if early intervention is needed.
2
Evaluate the patient's immunization needs for the 12-month well-child visit.
Routine immunizations due at 12 months include Hib, PCV, HepA, MMR, and Varicella.
To provide routine preventive care based on the standard immunization schedule.
3
Determine the impact of the patient's recent medical history (Kawasaki disease treated with IVIG) on his vaccination schedule.
High-dose IVIG contains antibodies that interfere with live-attenuated vaccines. Therefore, MMR and varicella must be deferred for 11 months post-IVIG.
To ensure vaccine efficacy.

Key Concept

Administration of live-attenuated vaccines (like MMR and varicella) must be deferred for up to 11 months following high-dose IVIG therapy, but inactivated vaccines should be given on schedule. Independent walking is not expected until 12-15 months.
Question 322Question →

A 1-week-old male newborn is brought to the pediatric clinic for his initial newborn follow-up visit. He was born at 39 weeks gestation via an uncomplicated spontaneous vaginal delivery to a 28-year-old primigravida. His birth weight was 3.4 kg (7 lb 8 oz). Current vital signs include a temperature of 36.8°C (98.2°F), heart rate of 140/min, and respiratory rate of 40/min. Physical examination reveals a healthy, vigorous neonate with normal muscle tone, a flat anterior fontanelle, and symmetric primitive reflexes. He received the first dose of the hepatitis B vaccine at birth and is feeding well on demand. His first-time parents are eager to understand what to expect regarding his neurodevelopmental progress over the coming years.

Arrange the following developmental milestone clusters in the chronological order of their expected emergence in a typically developing healthy child.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 4 months (brings hands to midline, laughs), 9 months (pulls to stand, stranger anxiety), 18 months (runs, 4-block tower), 3 years (pedals tricycle, 3-word sentences), and 5 years (copies triangle, catches ball).
Normal pediatric development follows a predictable sequence that must be understood for effective health maintenance and anticipatory guidance. At 4 months, infants bring their hands to the midline and laugh. By 9 months, they pull to stand and demonstrate stranger anxiety. At 18 months, a toddler has progressed to running and can stack a tower of four blocks. A 3-year-old typically achieves the classic milestones of pedaling a tricycle and speaking in three-word sentences. Finally, a 5-year-old possesses the advanced fine motor control to copy a triangle and the coordination to catch a bounced ball.

Step-by-Step Solution

1
Determine the expected age for the cluster: 'Brings hands to the midline and laughs aloud.'
This corresponds to the 4-month well-child visit milestones.
By 4 months, infants develop the motor control to engage their hands at the midline and begin laughing spontaneously.
2
Determine the expected age for the cluster: 'Pulls to a standing position and exhibits stranger anxiety.'
This corresponds to the 9-month well-child visit milestones.
At 9 months, core strength allows for pulling to stand, and cognitive development triggers stranger anxiety.
3
Determine the expected age for the cluster: 'Runs independently and builds a tower of four blocks.'
This corresponds to the 18-month well-child visit milestones.
Independent running and the fine motor precision to stack 4 blocks (but not yet 6) consolidate around 18 months.
4
Determine the expected age for the cluster: 'Pedals a tricycle and speaks in three-word sentences.'
This corresponds to the 3-year (36 months) well-child visit milestones.
A 3-year-old characteristically achieves 'rules of 3': 3-word sentences, riding a tricycle (3 wheels), and copying a 1-line closed shape (circle).
5
Determine the expected age for the cluster: 'Copies a triangle and catches a bounced ball.'
This corresponds to the 5-year (60 months) well-child visit milestones.
Copying complex shapes with intersecting oblique lines (triangle) and catching a ball require mature 5-year-old coordination.
6
Arrange the identified ages in chronological order.
4 months, 9 months, 18 months, 36 months, 60 months.
This establishes the correct temporal sequence of typical developmental emergence.

Key Concept

Normal pediatric growth and development follow a predictable chronological sequence across gross motor, fine motor, language, and social domains, which is actively monitored during scheduled preventive care visits.
Estimated Time:1m 0s
Question 323Question →

Match the following key socioemotional and play milestones to the most typical chronological age at which they first emerge during normal pediatric development.

Click a left item, then click its matching right item

Items

2 months
6 months
9 months
24 months (2 years)
48 months (4 years)

Matches

Show answer & explanation

Answer

The correct matching correctly aligns normal socioemotional development: 2 months with the social smile, 6 months with stranger anxiety, 9 months with separation anxiety, 24 months with parallel play, and 48 months with cooperative play.
Each socioemotional milestone aligns with highly standardized pediatric developmental timelines. Two-month-olds begin to smile socially. Six-month-olds recognize their primary caregivers and exhibit fear of strangers. Nine-month-olds understand that caregivers still exist even when out of sight, causing separation anxiety. Two-year-olds play alongside peers independently (parallel play), and four-year-olds play together with shared goals (cooperative play).

Step-by-Step Solution

1
Identify the earliest social milestone, the social smile.
The social smile reliably appears at 2 months of age.
This is the first major reciprocal socioemotional milestone assessed in well-child visits.
2
Differentiate between the onset of stranger anxiety and separation anxiety.
Stranger anxiety typically emerges around 6 months, followed by separation anxiety at 9 months.
Stranger anxiety relies on recognizing familiar versus unfamiliar faces. Separation anxiety requires the subsequent development of object permanence.
3
Distinguish between types of play based on the child's age in years.
Parallel play matches 24 months (2 years), while cooperative play matches 48 months (4 years).
Toddlers lack the theory of mind required for shared goals (parallel play), whereas preschool-aged children develop the capacity to negotiate rules and share tasks (cooperative play).

Key Concept

Normal socioemotional and play development in pediatrics follows a predictable chronological sequence, progressing from basic interpersonal responses to complex peer interactions.
Question 324Question →

A 30-month-old boy is brought to the office by his parents for a routine well-child visit. His parents express concern regarding his development. They note that he does not play cooperatively with other children at the local park, preferring to play independently next to them, and he frequently refuses to share his toys. Additionally, they are worried because he cannot yet pedal a tricycle or draw a circle. On physical examination, the child is active and cooperative. He walks up the examination step stool by placing both feet on each step and successfully jumps in place. He builds a tower of eight blocks and holds a crayon to make vertical lines. He speaks in two- to three-word phrases, has a vocabulary of approximately 100 words, and refers to himself as "I." His speech is understood by the physician roughly half the time. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassure the parents that his development is age-appropriate

Answer

Reassure the parents that his development is age-appropriate.
The correct action is to provide reassurance. The patient is exhibiting entirely normal milestones for a 30-month-old (2.5 years). He demonstrates appropriate gross motor skills (jumping in place, walking up stairs placing both feet on a step), fine motor skills (tower of 8 blocks, vertical line), language skills (100 words, 2-word phrases, 50% intelligible), and social skills (parallel play). The parents' concerns refer to milestones that are not expected until age 3 (riding a tricycle, copying a circle) or age 4 (cooperative play).

Step-by-Step Solution

1
Evaluate the parents' specific developmental concerns against established pediatric milestones.
Pedaling a tricycle (gross motor) and drawing a circle (fine motor) are expected at 3 years (36 months). Cooperative play and sharing (social) emerge near 4 years.
Parents frequently misinterpret advanced milestones as delays if they are unaware of the normal developmental timeline.
2
Assess the patient's currently demonstrated skills.
The patient jumps in place (gross motor, 30 mo), builds an 8-block tower (fine motor, 30 mo), speaks in 2-3 word phrases with 50% intelligibility (language, 24-30 mo), and engages in parallel play (social, 24-36 mo).
Establishing the child's actual developmental age across all four domains (gross motor, fine motor, language, social) is necessary to rule out isolated or global delays.
3
Determine the appropriate clinical intervention based on the findings.
Because all evaluated domains map perfectly to a 30-month-old developmental stage, no formal referrals or targeted screenings are indicated.
When a child's development is normal, the standard of care is reassurance and anticipatory guidance.

Key Concept

Normal pediatric developmental milestones at 2.5 to 3 years of age, distinguishing between expected toddler behaviors and actual developmental delays.
Question 325Question →

Parents bring their 2-year-old son to the pediatric clinic because they are highly concerned about his frequent, severe temper tantrums. When he is denied a toy, he frequently throws himself on the floor, kicks, and screams. During the most severe episodes, he cries vigorously, stops breathing, and turns slightly blue around the lips before taking a deep breath and recovering spontaneously. He has never lost consciousness.

On developmental assessment, the boy walks well, runs, kicks a ball, and can build a tower of 6 cubes. He points to objects he wants and brings books to his parents to read. His vocabulary consists of "mama," "dada," "dog," and "no." He does not put two words together. He makes good eye contact, smiles reciprocally, and plays alongside his older sister in the waiting room.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Formal audiometric testing

Answer

The correct answer is formal audiometric testing.
The correct action is to order a formal hearing assessment. This patient exhibits normal gross motor, fine motor, and social development for a 24-month-old. His tantrums and cyanotic breath-holding spells, which occur in the setting of frustration and are followed by rapid spontaneous recovery, are benign and represent a normal phase of toddler behavioral development. However, his expressive language is significantly delayed. At 24 months of age, a typically developing toddler should have an expressive vocabulary of at least 50 words and should be forming 2-word phrases (e.g., "want milk," "go bye-bye"). Because isolated speech and language delay can be the first and only sign of hearing impairment (often acquired through silent otitis media with effusion), formal audiometry is universally indicated as the first step in evaluation before initiating speech therapy or pursuing more extensive neurodevelopmental testing.

Step-by-Step Solution

1
Evaluate the chief complaint (temper tantrums and breath-holding spells).
Identify these behaviors as normal variations of toddler autonomy (benign cyanotic breath-holding spells) requiring no medical intervention.
Differentiating pathological neurological events from benign developmental behaviors prevents unnecessary testing.
2
Analyze the developmental milestones across all domains for a 24-month-old (2 years).
Gross motor (runs, kicks ball), fine motor (6-cube tower), and social (parallel play, eye contact) domains are completely normal. Language domain is delayed (only 4 words, no 2-word phrases).
Normal language development at 24 months requires a vocabulary of 50 to 200 words and the ability to combine 2 words into short phrases.
3
Determine the first step in the workup of an isolated speech/language delay.
Select formal hearing assessment (audiometry).
Undiagnosed hearing loss (e.g., from recurrent otitis media) is a leading cause of speech delay. Hearing must be formally evaluated before initiating speech therapy or other neurodevelopmental testing.

Key Concept

Any pediatric patient presenting with a speech or language delay must undergo a formal hearing assessment as the first diagnostic step, even if the newborn hearing screen was normal.
Question 326Question →

A 5-year-old boy is brought to the clinic for a well-child examination prior to starting kindergarten. His medical history is notable for severe polyarticular juvenile idiopathic arthritis. For the past 6 months, his condition has been exceptionally well controlled on a regimen of subcutaneous etanercept and oral methotrexate. His mother states he has been entirely asymptomatic. A review of his immunization records shows that he received all required infant and toddler vaccinations up to age 2, but he has not yet received any of his standard preschool booster vaccines. The mother also expresses concern that her son cannot yet copy a diamond or independently tie his shoelaces. Observation in the clinic reveals he can skip, copy a triangle, and accurately count to 10. Vital signs and physical examination are normal. Which of the following is the most appropriate management plan for this patient today?

Show answer & explanation

Answer: Administer DTaP and IPV; reassure the mother regarding his development

Answer

Administer DTaP and IPV; reassure the mother regarding his development
The correct management plan involves administering the inactivated vaccines (DTaP and IPV) while deferring the live-attenuated vaccines (MMR and varicella). This 5-year-old patient is severely immunocompromised due to his treatment with etanercept (a biologic agent) and methotrexate. Live-attenuated vaccines pose a risk of uncontrolled replication and disseminated disease in such patients and are therefore strictly contraindicated. Conversely, inactivated vaccines are safe and should be given on schedule to provide protection, even though the total immune response may be blunted. Regarding development, his ability to skip, copy a triangle, and count to 10 confirms normal 5-year-old milestones. His inability to copy a diamond or tie his shoelaces is appropriate for his age, as these are typically mastered at age 6; therefore, reassurance is the correct action.

Step-by-Step Solution

1
Determine the required vaccines for a 5-year-old child.
The standard preschool boosters given between 4 and 6 years of age are DTaP, IPV, MMR, and varicella.
Identifying the baseline requirement is necessary before adjusting for the patient's specific medical conditions.
2
Evaluate the patient's immune status based on current medications.
The patient is taking etanercept (a TNF-alpha inhibitor) and methotrexate, which cause significant immunosuppression.
Immunosuppression status dictates the safety profile of different vaccine types.
3
Apply vaccine contraindication guidelines for immunocompromised patients.
Live-attenuated vaccines (MMR, varicella) are strictly contraindicated, but inactivated vaccines (DTaP, IPV) are safe and should be administered.
Live vaccines can cause disseminated, life-threatening infections in immunosuppressed hosts, whereas inactivated vaccines pose no such risk.
4
Assess the patient's developmental milestones against age expectations.
Skipping, copying a triangle, and counting to 10 are normal 5-year-old milestones. Tying shoelaces and copying a diamond are typical 6-year-old milestones.
Determining if the mother's concern is valid dictates whether reassurance or a specialist referral is appropriate.

Key Concept

Live-attenuated vaccines are contraindicated in severely immunocompromised patients, whereas inactivated vaccines remain indicated. Additionally, tying shoelaces and copying a diamond are typical 6-year-old milestones, not 5-year-old milestones.
Estimated Time:1m 30s
Question 327Question →

A 4-year-old boy is brought to the pediatric clinic in late September for a well-child visit. He was diagnosed with moderate-to-severe Crohn disease 6 months ago. His current medications include infliximab, a tumor necrosis factor-alpha (TNF-α) inhibitor, which has led to clinical remission and appropriate weight gain. He has no other medical conditions. His immunizations were up to date until his 18-month visit. He is now due for his routine preschool vaccinations, and the parents also request the seasonal influenza vaccine. His vital signs are temperature 36.8°C (98.2°F), heart rate 98/min, and respiratory rate 20/min. Physical examination is unremarkable.

Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, IPV, and inactivated influenza vaccines; defer MMR and varicella vaccines

Answer

The most appropriate plan is to administer the inactivated vaccines (DTaP, IPV, and inactivated influenza) and to defer the live-attenuated vaccines (MMR and varicella).
The correct plan involves administering only the inactivated vaccines (DTaP, IPV, and inactivated influenza) and deferring the live-attenuated vaccines (MMR and varicella). This patient is receiving infliximab, a TNF-α inhibitor, which is a potent immunosuppressant. In severely immunocompromised patients, live-attenuated vaccines are strictly contraindicated because the vaccine strain viruses can undergo uncontrolled replication, leading to severe and potentially fatal disseminated disease. Conversely, inactivated vaccines cannot cause infectious disease and are safe to administer to immunocompromised individuals. They should be given on schedule to provide necessary protection, even though the overall immune response might be slightly blunted.

Step-by-Step Solution

1
Evaluate the patient's immune status based on his current medications.
The patient is taking infliximab, a biologic TNF-α inhibitor, which causes significant systemic immunosuppression.
Determining the immune status is the critical first step before administering any vaccines, as it dictates vaccine safety.
2
Determine the safety profile of the indicated preschool vaccines (DTaP, IPV, MMR, varicella, and seasonal influenza) in an immunocompromised host.
DTaP, IPV, and standard seasonal influenza vaccines are inactivated and safe. MMR and varicella are live-attenuated vaccines and are contraindicated.
Live-attenuated vaccines can cause uncontrolled viral replication and severe disease in immunocompromised patients, whereas inactivated vaccines pose no infectious risk.
3
Formulate the appropriate immunization plan for today's visit.
The plan must include the administration of the safe inactivated vaccines (DTaP, IPV, influenza) and the deferral of the contraindicated live vaccines (MMR, varicella).
This strategy maximizes the patient's protection against vaccine-preventable diseases without exposing him to the dangers of live vaccine administration.

Key Concept

In severely immunocompromised pediatric patients, such as those on TNF-α inhibitors, live-attenuated vaccines (e.g., MMR, varicella) are strictly contraindicated due to the risk of disseminated infection, whereas inactivated vaccines (e.g., DTaP, IPV) are safe and should be administered according to the routine schedule.
Estimated Time:1m 30s
Question 328Question →

A 2-day-old male newborn is evaluated in the nursery for a new-onset skin rash. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Apgar scores were 8 and 9 at 1 and 5 minutes, respectively. The infant has been breastfeeding well and has had normal bowel and bladder function. Temperature is 37.1 C (98.8 F), heart rate is 140/min, and respiratory rate is 40/min. Physical examination reveals multiple erythematous macules and papules with central 1- to 2-mm yellow-white pustules scattered across the trunk and proximal extremities. The palms and soles are spared. The remainder of the examination is unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and observation

Answer

Reassurance and observation
The correct answer is reassurance and observation. The patient presents with classic features of erythema toxicum neonatorum (ETN), a benign, idiopathic eruption seen in up to 50% of full-term neonates. ETN typically appears in the first 24 to 72 hours of life and is characterized by erythematous macules, papules, and pustules distributed predominantly over the trunk and proximal extremities, sparing the palms and soles. The infant is otherwise entirely asymptomatic and well-appearing. The condition is self-limited, usually resolving without scarring within one week, so no diagnostic workup or pharmacologic treatment is necessary.

Step-by-Step Solution

1
Evaluate the clinical status of the patient.
The neonate is full-term, afebrile, feeding well, and has reassuring vital signs.
Establishing that the infant is well-appearing helps rule out serious systemic infections (e.g., neonatal sepsis, disseminated herpes simplex virus).
2
Analyze the morphology and distribution of the rash.
The rash consists of erythematous macules and papules with central yellow-white pustules on the trunk and proximal extremities, sparing palms and soles.
This specific morphological pattern and distribution on day 2 of life is highly characteristic of erythema toxicum neonatorum.
3
Determine the appropriate management.
No diagnostic testing or pharmacologic intervention is recommended; the family should be reassured.
Erythema toxicum neonatorum is a benign, self-limited, idiopathic condition that spontaneously resolves within a week.

Key Concept

Erythema toxicum neonatorum is a common, benign, self-limiting neonatal rash presenting as erythematous macules with central pustules on the trunk and extremities, managed solely with reassurance.
Question 329Question →

A 2-month-old girl is brought to the clinic for her first well-child examination. She was born at 39 weeks gestation via spontaneous vaginal delivery. Her mother has a history of severe, refractory Crohn's disease, which has been managed with regular infusions of infliximab throughout the pregnancy, with the final dose administered at 36 weeks gestation. The infant's newborn screen was normal. She has been exclusively breastfed and is gaining weight well. On examination, the infant appears well. She smiles responsively, makes cooing sounds, and tracks the examiner's face past the midline. When placed in the prone position, she is able to lift her head to 45 degrees. The mother expresses concern that the infant is not yet reaching for objects or rolling over. Her tone and reflexes are normal. She previously received the Hepatitis B vaccine at birth. Which of the following is the most appropriate next step in management regarding her immunizations and development?

Show answer & explanation

Answer: Reassure the mother regarding development; administer DTaP, Hib, PCV, IPV, and Hepatitis B vaccines; and withhold the rotavirus vaccine

Answer

The most appropriate management is to reassure the mother regarding the infant's normal development, administer all routine inactivated vaccines (DTaP, Hib, PCV, IPV, Hepatitis B), and withhold the live rotavirus vaccine.
The correct management is to reassure the mother regarding the infant's normal development, administer the routine inactivated vaccines, and withhold the live rotavirus vaccine. At 2 months of age, normal milestones include social smiling, cooing, tracking past the midline, and lifting the head to 45 degrees when prone. The mother's concerns regarding the lack of reaching for objects and rolling over are unfounded, as these are typically 4-month milestones; therefore, reassurance is appropriate rather than a developmental referral. Regarding immunizations, the routine 2-month schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus. However, this infant was exposed to infliximab (a TNF-alpha inhibitor) in utero during the third trimester. Monoclonal IgG antibodies actively cross the placenta and can cause profound immunosuppression in the infant for up to 6 months after birth. Consequently, the administration of live-attenuated vaccines, such as the oral rotavirus vaccine, is strictly contraindicated during this period due to the risk of severe, disseminated vaccine-strain infection. In contrast, all inactivated vaccines are safe and should be administered according to the normal schedule.

Step-by-Step Solution

1
Assess the infant's developmental milestones.
The infant smiles, coos, tracks past the midline, and lifts her head 45 degrees when prone. The lack of reaching and rolling over is entirely normal at 2 months of age.
To address the mother's concerns and determine if a developmental referral is clinically warranted.
2
Determine the routine immunization requirements at 2 months of age.
The standard schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus vaccines.
To establish the baseline recommended vaccines before considering maternal and patient history for contraindications.
3
Identify any contraindications based on the infant's in utero exposure.
The infant was exposed to infliximab (an IgG1 monoclonal antibody) in utero. These biologic agents actively cross the placenta and cause systemic immunosuppression in the infant that can persist for up to 6 months.
Maternal use of biologic immunosuppressants dictates the safety profile of live vaccines in the neonate.
4
Synthesize the findings to formulate the safest management plan.
Reassure the mother about development. Administer all inactivated vaccines, as they are safe. Withhold the live rotavirus vaccine to prevent disseminated vaccine-strain infection.
To provide necessary preventive care while avoiding life-threatening complications in an immunocompromised host.

Key Concept

Infants exposed to biological immunomodulators (e.g., infliximab, adalimumab) in utero during the second or third trimester should not receive live-attenuated vaccines (like rotavirus) for the first 6 months of life, though all inactivated vaccines should be administered on the standard schedule.
Question 330Question →

During routine well-child visits, developmental surveillance is a critical component of preventive care. Arrange the following communication and language milestones in the correct chronological order of their typical emergence in a healthy developing child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological progression of language milestones is: cooing (2 months), babbling (6 months), saying 'mama' or 'dada' specifically (12 months), combining words into two-word phrases (24 months), and telling a simple story (4 years).
Language development follows a predictable, chronological pattern. It starts with simple vowel sounds (cooing at 2 months), progresses to consonant-vowel combinations (babbling at 6 months), meaningful single words ('mama/dada' specifically at 12 months), simple word combinations (two-word phrases at 24 months), and ultimately advances to complex narrative skills (telling a story at 4 years).

Step-by-Step Solution

1
Identify the earliest infant vocalization milestone.
Cooing is the first milestone, emerging at 2 months.
Infants begin producing simple vowel sounds before they develop the motor control to articulate consonants.
2
Identify the next stage of vocal development.
Babbling with consonant-vowel sounds emerges at 6 months.
As infants gain better control over their lips and tongue, they add basic consonants to their vocalizations.
3
Determine when words are first used with specific meaning.
Saying 'mama' or 'dada' specifically to the parents occurs at 12 months.
Although non-specific repetition happens earlier (around 9 months), assigning meaning and directing the words correctly is a 12-month milestone.
4
Identify the emergence of early word combinations.
Combining words into two-word phrases occurs at 24 months.
At 2 years of age, toddlers typically experience a language explosion, linking their growing vocabulary to form basic sentences.
5
Identify the most advanced language milestone in the list.
Telling a simple story occurs at 4 years.
This stage requires advanced vocabulary, grammatical structure, and narrative understanding.

Key Concept

Chronological progression of normal language and communication milestones in pediatric development.
Estimated Time:1m 0s
Question 331Question →

A mother brings her daughter, aged 4 years and 2 months, to the pediatric clinic for a health maintenance visit. The child was diagnosed with minimal change disease one month ago and has been taking daily oral prednisone at a dose of 2 mg/kg for the past 24 days. Her vital signs are within normal limits for her age, and physical examination reveals mild facial puffiness but is otherwise unremarkable. The mother expresses concern regarding her daughter's development, noting that the child can hop on one foot and copy a cross, but is unable to skip or draw a person with more than three body parts. A review of the electronic health record shows the patient received all recommended infant and toddler immunizations up to 18 months of age, but she has not yet received any of her preschool vaccine boosters. Which of the following is the most appropriate management regarding this patient's immunizations and development?

Show answer & explanation

Answer: Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones

Answer

Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones
This patient requires her preschool booster vaccines but is currently significantly immunosuppressed due to high-dose systemic corticosteroid therapy (prednisone at 2 mg/kg/day for >14 days). In this state, live-attenuated vaccines (such as measles-mumps-rubella and varicella) are strictly contraindicated due to the risk of severe, disseminated vaccine-strain infection. However, inactivated vaccines (such as diphtheria-tetanus-acellular pertussis and inactivated poliovirus) are safe and should be administered on schedule. Furthermore, the child's development is entirely age-appropriate. At 4 years of age, normal milestones include hopping on one foot, copying a cross, and drawing a person with 3 body parts. Skipping, copying a triangle, and drawing a person with 6 body parts are expected at 5 years of age. Therefore, the mother should be reassured, and no developmental referral is needed.

Step-by-Step Solution

1
Evaluate the patient's immune status based on her medication regimen.
The patient is taking prednisone at 2 mg/kg/day for over 14 days, which qualifies as highly immunosuppressive corticosteroid therapy.
To determine whether she has any immune-related contraindications to her scheduled preschool vaccines.
2
Determine which preschool vaccines are safe to administer.
Inactivated vaccines (DTaP, IPV) are safe to administer, while live-attenuated vaccines (MMR, varicella) are strictly contraindicated and must be deferred until at least one month after steroid cessation.
Live vaccines can cause fatal disseminated infections in immunocompromised hosts, whereas inactivated vaccines pose no such risk.
3
Assess the patient's developmental milestones relative to her chronological age.
The child can hop and copy a cross (expected 4-year milestones) but cannot skip or draw a 6-part person (expected 5-year milestones). This is perfectly normal for a 4-year-old.
To address the mother's concern and decide if a neurodevelopmental referral is clinically indicated.

Key Concept

High-dose systemic corticosteroids (2 mg/kg/day or 20 mg/day of prednisone for 14 or more days) are a contraindication for live-attenuated vaccines, but inactivated vaccines may be safely administered. Skipping and drawing a 6-part person are 5-year milestones, not 4-year milestones.
Question 332Question →

Match the following classic clinical descriptions of benign neonatal skin findings with their most likely diagnoses.

Click a left item, then click its matching right item

Items

Erythematous macules with central yellow-white papules on the trunk and extremities, showing prominent eosinophils on microscopic evaluation.
Firm, pearly-white papules on the nose and cheeks of a newborn, consisting of superficial epidermal keratin cysts.
Flat, blue-gray macular patches with poorly defined margins, typically found on the lumbosacral region of dark-skinned infants.
Vesiculopustular rash without surrounding erythema that quickly ruptures, leaving hyperpigmented macules and showing neutrophils on microscopy.

Matches

Show answer & explanation

Answer

The correct matches are: Erythematous macules with eosinophils match Erythema toxicum neonatorum. Pearly-white keratin cysts match Milia. Blue-gray sacral macules match Congenital dermal melanocytosis. Vesiculopustules without erythema showing neutrophils match Transient neonatal pustular melanosis.
Each clinical description maps uniquely to a classic, benign neonatal skin condition. Recognizing these patterns is essential to avoid unnecessary testing or treatments and to provide appropriate reassurance to parents.

Step-by-Step Solution

1
Analyze the microscopic contents and visual appearance of the vesicular/pustular rashes.
Eosinophils identify erythema toxicum neonatorum, while neutrophils identify transient neonatal pustular melanosis. Keratin identifies milia.
Differentiating these benign rashes often relies on the cellular contents of the lesions.
2
Evaluate the non-pustular, pigmented lesions based on color and location.
Blue-gray pigmentation on the sacrum perfectly describes congenital dermal melanocytosis.
Identifying characteristic pigmentation patterns prevents misdiagnosing benign lesions as child abuse (bruising).

Key Concept

Benign Neonatal Dermatological Findings
Question 333Question →

A pediatric clinic is creating a quick-reference chart for residents to use during routine well-child evaluations. The chart aims to integrate various developmental domains across the first three years of life. Arrange the following key developmental milestones in their correct chronological sequence of expected acquisition, starting with the earliest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Demonstrates a social smile (2 months) -> Sits momentarily without support (6 months) -> Pulls to a standing position (9 months) -> Uses a mature pincer grasp (10-12 months) -> Combines words into two-word phrases (24 months) -> Pedals a tricycle (36 months).
Normal pediatric development follows a predictable chronological sequence across multiple domains. The social smile is an early personal-social milestone typically appearing by 2 months of age. Postural control develops cephalocaudally; sitting without support emerges around 6 months, followed by the ability to pull to a standing position at 9 months. Fine motor skills concurrently progress, with the mature pincer grasp (using the pads of the index finger and thumb) developing by 10 to 12 months. Language and advanced motor skills emerge later, with two-word phrases expected by 24 months (2 years) and pedaling a tricycle by 36 months (3 years).

Step-by-Step Solution

1
Identify the earliest milestone in infancy.
Demonstrates a social smile
The social smile is one of the earliest reliable social milestones, expected at 2 months of age.
2
Sequence the remaining milestones occurring in the first year of life.
Sits momentarily without support, then Pulls to a standing position, then Uses a mature pincer grasp.
Gross motor development progresses cephalocaudally. Sitting unsupported occurs around 6 months, pulling to a stand occurs around 9 months, and the fine motor mature pincer grasp develops around 10 to 12 months.
3
Sequence the milestones occurring in early childhood (2-3 years).
Combines words into two-word phrases, then Pedals a tricycle.
Two-word phrases typically emerge at 2 years (24 months), and pedaling a tricycle is classically achieved at 3 years (36 months).

Key Concept

Chronological acquisition of key developmental milestones
Estimated Time:1m 0s
Question 334Question →

A 12-month-old boy is brought to the clinic for a routine well-child visit. His mother reports that he pulls to a stand and cruises along furniture, but she is concerned because he is not yet walking independently. He uses a neat pincer grasp to pick up small pieces of food. He says "mama" and "dada" specifically to his parents but uses no other recognizable words. He plays peek-a-boo and waves goodbye. The boy is due for his routine 12-month immunizations, which include the live-attenuated measles-mumps-rubella (MMR) and varicella vaccines. However, his 6-year-old sister recently underwent a hematopoietic stem cell transplant for acute myeloid leukemia and is currently severely immunocompromised. The mother asks if it is safe for the boy to receive his scheduled vaccines given his sister's condition. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassure the mother regarding his development and administer the MMR and varicella vaccines.

Answer

Reassure the mother regarding his development and administer the MMR and varicella vaccines.
The correct action is to reassure the mother that her child's development is perfectly on track and to administer the scheduled MMR and varicella vaccines. At 12 months of age, normal milestones include cruising, using a neat pincer grasp, saying 'mama' and 'dada' specifically, and playing social games like peek-a-boo. The lack of independent walking at exactly 12 months is a normal variant and does not require a developmental referral. Regarding immunizations, the Centers for Disease Control and Prevention (CDC) strongly recommends that healthy individuals who live with immunocompromised patients receive all routine vaccinations, including live-attenuated vaccines like MMR and varicella. This 'cocooning' strategy creates a ring of immunity around the vulnerable patient, protecting them from wild-type pathogens which cause significantly more severe disease than vaccine-strain viruses. The MMR vaccine viruses are not transmitted to contacts. While the varicella vaccine virus can rarely be transmitted if the vaccinee develops a localized vesicular rash (occurring in about 5% of cases), the recommendation remains to vaccinate; the family should simply be advised to separate the infant from the sister only if such a rash appears.

Step-by-Step Solution

1
Evaluate the child's developmental milestones for a 12-month-old infant.
Gross motor (pulls to stand, cruises), fine motor (neat pincer grasp), language ('mama'/'dada' specifically), and social (peek-a-boo, waving) are all age-appropriate. Not walking independently is normal at this age.
To determine if a developmental referral is warranted.
2
Assess the contraindications for administering live-attenuated vaccines to a patient with an immunocompromised household contact.
Healthy household contacts of immunocompromised individuals should receive routine live-attenuated vaccines (MMR, Varicella, Rotavirus) to prevent wild-type infection transmission.
To determine the safest immunization plan that protects both the patient and the severely immunocompromised sibling.
3
Synthesize the findings to select the best management strategy.
Reassure the mother about the normal milestones and proceed with administering both the MMR and varicella vaccines.
This strategy provides appropriate anticipatory guidance and adheres to CDC/AAP immunization guidelines for 'cocooning' immunocompromised individuals.

Key Concept

Healthy household contacts of severely immunocompromised patients should receive all routine age-appropriate live-attenuated vaccines (including MMR and varicella) to protect the immunocompromised family member from dangerous wild-type infections. Furthermore, independent walking is a 12- to 15-month milestone, and its absence at exactly 12 months is normal.
Estimated Time:1m 30s
Question 335Question →

An 18-month-old toddler is evaluated at a primary care clinic after relocating from another state. The parents note that he has had nasal congestion and a mild cough for the past 48 hours. His temperature is 37.8°C (100.0°F), pulse is 110/min, and respirations are 24/min. Physical examination demonstrates clear rhinorrhea and a mildly erythematous posterior oropharynx. Auscultation reveals clear breath sounds bilaterally without wheezing or crackles. He is playful, runs around the examination room, scribbles on a piece of paper, and uses approximately 15 different words. Review of his medical record indicates that his last immunizations were administered at the age of 6 months. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer all overdue age-appropriate vaccines today

Answer

Administer all overdue age-appropriate vaccines today
The correct course of action is to administer all overdue age-appropriate vaccines simultaneously. A cornerstone of pediatric preventive care is minimizing missed opportunities for immunization. According to standard guidelines, mild acute illness (e.g., upper respiratory tract infection, mild diarrhea, otitis media), with or without a low-grade fever, is a false contraindication to vaccination. Because this patient is significantly behind on his immunization schedule (last vaccinated at 6 months of age), it is crucial to update his vaccines today. Both inactivated and live-attenuated vaccines can and should be administered safely in this clinical scenario.

Step-by-Step Solution

1
Evaluate the patient's current clinical presentation to identify any true contraindications to vaccination.
The patient has a mild upper respiratory tract infection with a low-grade fever.
Moderate to severe acute illness (with or without fever) is a valid precaution for vaccination, but mild illness is a false contraindication.
2
Assess the patient's developmental milestones to rule out any underlying neurological or developmental conditions.
The patient's motor skills (running, scribbling) and language skills (15 words) are completely normal for an 18-month-old.
Accurately identifying normal development prevents unnecessary specialist referrals that could distract from required preventive care.
3
Determine the appropriate immunization strategy based on the patient's age and previous vaccine history.
The patient is overdue for multiple vaccines since his last visit was at 6 months of age. All eligible vaccines should be given simultaneously.
Catch-up vaccination should be prioritized in healthy children to prevent missed opportunities for immunization, regardless of mild concurrent illness.

Key Concept

Mild acute illness, with or without low-grade fever, is a false contraindication to vaccination; all age-appropriate vaccines (both inactivated and live-attenuated) should be administered without delay.
Estimated Time:1m 0s
Question 336Question →

A medical student is preparing a comprehensive timeline of preventive care milestones to use during a pediatric clerkship. The student aims to map out the exact age at which specific universal screening tests are first introduced for a healthy, term, asymptomatic pediatric patient with no family history of genetic or metabolic disease. According to the American Academy of Pediatrics (AAP) Bright Futures guidelines, arrange the following universal screening interventions in chronological order based on the age they should FIRST be administered, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of first universal screenings is: General developmental screening (9 months), Anemia screening (12 months), Autism screening (18 months), Visual acuity testing (4 years), Dyslipidemia screening (9 to 11 years), and Major depressive disorder screening (12 years).
The American Academy of Pediatrics (AAP) Bright Futures guidelines establish a highly specific timeline for universal screening in asymptomatic children. The sequence begins with general developmental screening at 9 months. At 12 months, universal screening for anemia is indicated. At 18 months, an autism-specific screening tool is introduced. By 4 years of age, children are universally screened for visual acuity using optotype charts. Later in childhood, universal dyslipidemia screening is performed once between 9 and 11 years of age. Finally, universal screening for major depressive disorder begins at 12 years of age.

Step-by-Step Solution

1
Determine the initial age for general developmental screening.
9 months of age.
AAP guidelines recommend the first standardized general developmental screening at 9 months.
2
Determine the initial age for universal anemia screening.
12 months of age.
Term infants are universally screened for iron deficiency anemia via hemoglobin/hematocrit at 12 months, corresponding with the depletion of physiological iron stores and transition to cow's milk.
3
Determine the initial age for autism spectrum disorder screening.
18 months of age.
Autism-specific screening (e.g., M-CHAT) is universally initiated at the 18-month visit.
4
Determine the initial age for visual acuity screening using optotypes.
4 years of age.
Cooperation for visual acuity charts (optotypes) is generally sufficient by age 4, marking the start of this universal screening method.
5
Determine the initial age for universal dyslipidemia screening.
9 to 11 years of age.
A baseline lipid profile is obtained universally during this prepubertal window.
6
Determine the initial age for major depressive disorder screening.
12 years of age.
Annual universal screening for depression formally begins at age 12.

Key Concept

AAP Bright Futures Periodicity Schedule for Universal Pediatric Screening
Estimated Time:1m 30s
Question 337Question →

A 4-year-old girl is brought to the office by her father for a well-child examination. The father is worried about her overall development. He states that since she started attending a new preschool three months ago, she has frequently engaged in conversations with an "imaginary friend" in her bedroom. Furthermore, she intermittently repeats syllables when she is very eager to talk about her day. The father is also concerned because she is unable to draw a square or ride a two-wheeled bicycle, milestones that her older sibling had already achieved by age 5. Her medical history is unremarkable. On examination, the patient appears well-nourished and cooperative. She is able to hop on one foot and catch a bounced ball. When given paper and crayons, she successfully draws a person with four body parts and copies a cross, but she cannot draw a square or a triangle. During the visit, her speech is entirely understandable to the physician, and she exhibits no facial grimacing, jaw jerking, or eye blinking when repeating syllables. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance that her development is age-appropriate

Answer

Reassurance that her development is age-appropriate
The patient's presentation represents perfectly normal development for a 4-year-old child. At 4 years of age, normal motor milestones include hopping on one foot, catching a bounced ball, drawing a person with at least three body parts, and copying a cross. Copying a square, copying a triangle, and riding a two-wheeled bicycle are typical 5-year-old milestones, making it entirely normal that this 4-year-old cannot do them yet. Additionally, 100% speech intelligibility is expected by age 4, which she demonstrates. Developmental dysfluency—stuttering without secondary features like tics, eye blinking, or grimacing—is very common in preschool children, often occurs when they are excited, and typically self-resolves. Finally, imaginary companions are a healthy aspect of normal socioemotional development in children aged 3 to 6 years. Because all of these findings are benign, reassurance is the only appropriate intervention.

Step-by-Step Solution

1
Evaluate the patient's fine and gross motor development against age-based milestones.
The patient can draw a person with four parts, copy a cross, hop on one foot, and catch a bounced ball.
These findings represent expected 4-year-old milestones. Copying a square and riding a two-wheeled bicycle are 5-year-old milestones, explaining her inability to perform them yet.
2
Assess the patient's language development and the father's concern about stuttering.
Her speech is 100% intelligible with periods of dysfluency but no secondary behaviors like grimacing.
By age 4, a child's speech should be entirely understandable to strangers. Developmental dysfluency without secondary physical features is a normal variant that typically resolves spontaneously.
3
Analyze the significance of the patient's imaginary friend.
The presence of an imaginary friend in a 4-year-old child is identified as a normal behavioral finding.
Imaginary companions are a healthy part of socioemotional development in preschool-aged children and aid in creative processing.
4
Determine the next best step in management.
Since all findings are normal variants or age-appropriate, no specialized testing or therapy is needed.
Unnecessary referrals can cause undue parental anxiety and medicalize normal childhood development.

Key Concept

Normal developmental milestones in a 4-year-old include 100% speech intelligibility, hopping on one foot, copying a cross, and drawing a person with four body parts. Imaginary friends and developmental dysfluency (stuttering without secondary physical behaviors) are common normal variants at this age.
Estimated Time:1m 0s
Question 338Question →

Match each pediatric patient presenting for a routine well-child visit with the corresponding age-appropriate universal screening test recommended by the American Academy of Pediatrics.

Click a left item, then click its matching right item

Items

A 12-month-old asymptomatic boy with no significant medical or family history
An 18-month-old asymptomatic girl with typical development and growth
A 4-year-old asymptomatic boy preparing to start a preschool program
A 10-year-old asymptomatic girl with an active lifestyle
A 12-year-old asymptomatic boy attending the clinic for an annual physical examination

Matches

Show answer & explanation

Answer

The 12-month-old matches with hemoglobin measurement. The 18-month-old matches with the autism screening tool. The 4-year-old matches with objective visual acuity testing. The 10-year-old matches with a lipid profile. The 12-year-old matches with the standardized depression screening questionnaire.
The correct matches align with the American Academy of Pediatrics (AAP) periodicity schedule for universal screening. At 12 months, infants are universally screened for anemia. At 18 months, toddlers receive their first formal autism spectrum disorder screening. At 4 years, children are cognitively mature enough for objective visual acuity testing using a chart. Between ages 9 and 11 (e.g., 10 years old), children undergo universal dyslipidemia screening. At 12 years, universal depression screening begins for adolescents.

Step-by-Step Solution

1
Identify the purpose of the clinical encounter.
Each scenario describes a routine health maintenance examination for an asymptomatic pediatric patient at a specific age milestone.
This establishes that universal screening guidelines, rather than targeted risk-based guidelines, apply.
2
Recall the American Academy of Pediatrics (AAP) Bright Futures periodicity schedule.
Identify the specific universal screening tests uniquely introduced or emphasized at 12 months, 18 months, 4 years, 10 years, and 12 years.
Matching age milestones to screening protocols is a core competency in pediatric preventive care.
3
Pair each patient profile with the correct intervention.
12 months to anemia screening, 18 months to autism screening, 4 years to vision testing, 10 years to lipid screening, and 12 years to depression screening.
This completes the matching requirement based on established pediatric guidelines.

Key Concept

Universal Pediatric Screening Guidelines (AAP Bright Futures periodicity schedule)
Question 339Question →

A pediatric clinic is reviewing its protocols for routine health maintenance and immunization delivery. The clinical educator asks the medical students to outline the chronological progression of vaccinations. Arrange the following immunization milestones in chronological order based on the age at which they are routinely indicated for a healthy, full-term child in the United States, starting from the earliest intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with the standalone Hepatitis B vaccine at birth, followed by the initial DTaP/IPV/Hib/PCV/rotavirus series at 2 months, the introduction of MMR and varicella at 12 months, the preschool boosters at 4 to 6 years, and finally the adolescent Tdap/MenACWY/HPV platform at 11 to 12 years.
The sequence directly follows the CDC immunization schedule. The Hepatitis B vaccine is given at birth. The core inactivated infant series (plus oral rotavirus) begins at 2 months. Subcutaneous live vaccines (MMR, varicella) are withheld until 12 months to avoid maternal antibody interference. A major booster combination (DTaP, IPV, MMR, varicella) is given at 4 to 6 years before school entry. Finally, the adolescent platform (Tdap, MenACWY, HPV) is administered at 11 to 12 years.

Step-by-Step Solution

1
Identify the recommended age for the standalone Hepatitis B vaccination.
Birth (within 24 hours).
This is the only vaccine routinely administered in the newborn nursery to prevent vertical transmission.
2
Identify the recommended age for the initial DTaP, IPV, Hib, pneumococcal conjugate, and rotavirus series.
2 months of age.
The primary series for these core infant vaccines universally begins at the 2-month well-child visit.
3
Identify the recommended age for the first doses of subcutaneous live-attenuated vaccines (MMR and varicella).
12 to 15 months of age.
Administration is delayed until at least 12 months of age to prevent interference from passive maternal antibodies.
4
Identify the recommended age for the preschool boosters of DTaP, IPV, MMR, and varicella.
4 to 6 years of age.
These boosters are required to maintain immunity prior to the increased exposure risk of entering school.
5
Identify the recommended age for the adolescent vaccine platform (Tdap, MenACWY, HPV).
11 to 12 years of age.
This cluster of vaccines is specifically designed to provide protection against diseases with increased risk during adolescence and adulthood.
6
Sequence the interventions chronologically.
Birth -> 2 months -> 12-15 months -> 4-6 years -> 11-12 years.
This outlines the standard trajectory of the pediatric immunization schedule.

Key Concept

The CDC Recommended Child and Adolescent Immunization Schedule outlines a highly specific, age-based timeline for the introduction and boosting of vaccines to maximize immunogenicity and prevent disease outbreaks.
Question 340Question →

Match each neonatal clinical vignette with its primary underlying pathophysiology.

Click a left item, then click its matching right item

Items

A 39-week gestation infant delivered via elective cesarean section without antecedent labor develops tachypnea and retractions. Chest radiography demonstrates fluid in the minor fissure and prominent perihilar streaking.
A 29-week gestation neonate presents with grunting and cyanosis in the delivery room. Chest radiography reveals low lung volumes, a diffuse bilateral reticulogranular pattern, and prominent air bronchograms.
A 41-week gestation infant is born limp and cyanotic. The chest is barrel-shaped. Radiography reveals patchy, asymmetric bilateral infiltrates with hyperinflation and flattened hemidiaphragms.
A 38-week gestation infant develops severe hypoxemia and central cyanosis. The chest radiograph is relatively clear with normal lung volumes. Echocardiography shows right-to-left shunting across a patent foramen ovale and ductus arteriosus with structurally normal heart anatomy.

Matches

Show answer & explanation

Answer

Match Transient Tachypnea of the Newborn (TTN) to delayed fluid clearance, Respiratory Distress Syndrome (RDS) to surfactant deficiency, Meconium Aspiration Syndrome (MAS) to airway obstruction and pneumonitis, and Persistent Pulmonary Hypertension of the Newborn (PPHN) to failure of pulmonary vascular resistance decline.
Each clinical scenario correctly describes a classic presentation of a major neonatal respiratory disorder, and the corresponding correct match accurately defines the specific pathophysiologic mechanism for that disorder. The two-step reasoning requires identifying the disease (TTN, RDS, MAS, PPHN) and subsequently linking it to its physiologic disruption.

Step-by-Step Solution

1
Analyze the first vignette to determine the diagnosis.
The combination of term birth, elective cesarean section without labor, fluid in fissures, and perihilar streaking strongly indicates Transient Tachypnea of the Newborn (TTN).
Identifying the specific clinical syndrome is necessary to match it with its underlying pathophysiology.
2
Match TTN to its pathophysiology.
TTN is matched to 'Delayed resorption and clearance of fetal alveolar fluid...'
During vaginal labor, hormonal surges (like catecholamines) trigger the reabsorption of fetal lung fluid. Elective cesareans bypass this process, causing transient retained fluid.
3
Analyze the second vignette to determine the diagnosis.
The presentation of a premature infant with ground-glass opacities and air bronchograms is the classic description of Respiratory Distress Syndrome (RDS).
Recognizing the radiographic and clinical hallmark of RDS in prematurity.
4
Match RDS to its pathophysiology.
RDS is matched to 'Quantitative deficiency of type II pneumocyte secretions...'
Premature lungs lack sufficient surfactant production, leading to high alveolar surface tension, atelectasis, and hypoxemia.
5
Analyze the third vignette to determine the diagnosis.
A post-term infant with barrel-chest, hyperinflation, and asymmetric patchy opacities is characteristic of Meconium Aspiration Syndrome (MAS).
Identifying MAS based on post-term status and radiographic evidence of airway obstruction and inflammation.
6
Match MAS to its pathophysiology.
MAS is matched to 'Mechanical airway obstruction causing a ball-valve effect...'
Meconium physically blocks the airways (air trapping/hyperinflation) and causes a chemical pneumonitis that inactivates surfactant.
7
Analyze the fourth vignette to determine the diagnosis.
Severe hypoxemia out of proportion to lung disease, with right-to-left shunting on a structurally normal heart, points to Persistent Pulmonary Hypertension of the Newborn (PPHN).
Ruling out cyanotic congenital heart disease and identifying the functional shunting.
8
Match PPHN to its pathophysiology.
PPHN is matched to 'Failure of normal postnatal decline in pulmonary vascular resistance...'
High pulmonary pressures force blood to bypass the lungs via the patent foramen ovale and ductus arteriosus, causing systemic hypoxemia.

Key Concept

Neonatal respiratory distress conditions can be differentiated by gestational age, risk factors, and radiographic findings, which correlate directly with distinct pathophysiologic mechanisms.
PreviousPage 17 / 55Next
Pediatrics Practice Questions — USMLE Step 2 CK — Page 17 | Examkin